Jane K. Stock

Goeteborg, O 41251, Sweden

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 58 publications

Women, lipids, and atherosclerotic cardiovascular disease: a call to action from the European Atherosclerosis Society.

Women, lipids, and atherosclerotic cardiovascular disease: a call to action from the European Atherosclerosis Society.

Journal: European heart journal
Published: August 23, 2023

Frequent questions and responses on the 2022 lipoprotein(a) consensus statement of the European Atherosclerosis Society.

Frequent questions and responses on the 2022 lipoprotein(a) consensus statement of the European Atherosclerosis Society.

Journal: Atherosclerosis
Published: April 24, 2023

2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance.

2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance.

Journal: European heart journal
Published: August 15, 2022

Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement.

Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement.

Journal: European heart journal
Published: February 24, 2022

Homozygous Familial Hypercholesterolaemia International Clinical Collaboration (HICC) registry: Levelling up access to treatment urgently needed.

Homozygous Familial Hypercholesterolaemia International Clinical Collaboration (HICC) registry: Levelling up access to treatment urgently needed.

Journal: Atherosclerosis
Published: January 31, 2022

Novel insights into lipoprotein(a): News from Atherosclerosis.

Novel insights into lipoprotein(a): News from Atherosclerosis.

Journal: Atherosclerosis
Published: January 25, 2022

Joint statement from the European Atherosclerosis Society and European Society of Vascular Medicine focuses on patients with peripheral arterial disease.

Joint statement from the European Atherosclerosis Society and European Society of Vascular Medicine focuses on patients with peripheral arterial disease.

Journal: Atherosclerosis
Published: November 10, 2021

Global Familial Hypercholesterolaemia Studies Collaboration (FHSC).

Global Familial Hypercholesterolaemia Studies Collaboration (FHSC).

Journal: Atherosclerosis
Published: September 15, 2021

Lipid Clinics Network targets suboptimal guideline implementation.

Lipid Clinics Network targets suboptimal guideline implementation.

Journal: Atherosclerosis
Published: July 13, 2021

EAS Task Force gives practical guidance for combination lipid-modifying therapy in high- and very-high-risk patients.

EAS Task Force gives practical guidance for combination lipid-modifying therapy in high- and very-high-risk patients.

Journal: Atherosclerosis
Published: May 12, 2021

Practical guidance for combination lipid-modifying therapy in high- and very-high-risk patients: A statement from a European Atherosclerosis Society Task Force.

Practical guidance for combination lipid-modifying therapy in high- and very-high-risk patients: A statement from a European Atherosclerosis Society Task Force.

Journal: Atherosclerosis
Published: March 18, 2021

Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society.

Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society.

Journal: European heart journal
Published: March 15, 2021
Showing 1-12 of 58

Last Updated: 09/26/2026